Tutogen Medical (TTG) Announces Expansion of Partnership with Zimmer Dental (ZMH)
More News related to TTG
- Tutogen Medical (TTG) Reports Q4 Earnings
- Tutogen Medical (TTG) Up On Cramer's Comments
- StreetInsider.com Pre-Open Movers: 10/15
- Tutogen Medical (TTG) Announces Expansion of Partnership with Zimmer Dental (ZMH)
- Tutogen Medical (TTG) Tops Q3 EPS by 1c
More News related to ZMH
- Zimmer Holdings Announces 2010 Funding for OMeGA Medical Grants Association
- XCPT(R) Software Announces a Partnership Agreement to Advance Zimmer Dental Digital Dentistry Initiatives
- Zimmer Holdings (ZMH) Tops Q4 EPS by 4c; Guides
- Zimmer Reports Fourth Quarter and 2009 Financial Results
- Trading Radar for 01/28: Amazon.com (AMZN), Microsoft (MSFT), Chubb (CB), AT&T (T), Ford Motor (F), L-3 (LLL) Report
More News related to Corporate News
- S&P Announces Change to US Index: TSRA for FIF
- RealNetworks (RNWK) and MTV Networks (VIA-B) to Split Off Joint Venture Rhapsody
- Watts Water (WTS) Board Approves Restructuring Program; Shutting Down 3 Plants, Cutting 95 Jobs
- Transcept Pharmaceuticals (TSPT) Granted U.S. Patent Covering Intermezzo Formulation
- AAR (AIR) Predicts Impact of Mesa's Bankruptcy on Q3 Results
Zimmer Holdings, Inc. (NYSE: ZMH) and Tutogen Medical (AMEX: TTG) announced the expansion of Tutogen's partnership with Zimmer Dental Inc., a wholly owned subsidiary of Zimmer Holdings, Inc., into Europe, the Middle East and Asia. Zimmer Dental currently distributes Tutogen grafts in the United States, Canada and Latin America, under the brand name Puros. This enhanced distribution agreement includes both human and bovine tissues -- bone and soft tissue grafts -- and provides the dentist with a complete product package for the regenerative procedure.
The addressable market for Tutogen's dental products is estimated to be approximately $300 million annually, with the U.S. representing approximately one-half of the total.
Related Categories
Corporate NewsStocks Mentioned
+0.00Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
